EMMPRIN Antibodies

Santa Cruz Biotechnology features a diverse variety of EMMPRIN monoclonal antibodies for investigating EMMPRIN's role in various biological processes. EMMPRIN monoclonal antibodies are suitable for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA).EMMPRIN, also known as Basigin or CD147, is a transmembrane glycoprotein that plays a crucial role in cell-cell interactions and the regulation of matrix metalloproteinases (MMPs). EMMPRIN is involved in processes such as tumor progression, inflammation, and tissue remodeling, making it an important target for cancer research and therapeutic interventions. Understanding EMMPRIN's function can provide insights into its potential as a biomarker and therapeutic target in various diseases. EMMPRIN research has revealed significant implications in cardiovascular disorders, neurological conditions, and immune system responses. Recent studies have highlighted EMMPRIN's involvement in cellular metabolism and drug resistance mechanisms. Ongoing research continues to uncover new functions and pathways associated with EMMPRIN signaling. Santa Cruz Biotechnology monoclonal antibodies enable researchers worldwide to advance scientific understanding of EMMPRIN's role in human health and disease development.